James-Kevin Y Tan1, Binhan Pham1, Yujin Zong2, Camilo Perez3, Don O Maris4, Ashton Hemphill1, Carol H Miao5, Thomas J Matula6, Pierre D Mourad4, Hua Wei7, Drew L Sellers1, Philip J Horner8, Suzie H Pun9. 1. Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA. 2. Center for Industrial and Medical Ultrasound, University of Washington, Seattle, WA 98195, USA; Department of Biomedical Engineering, Xian Jiaotong University, Xi'an, 710049, China. 3. Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Center for Industrial and Medical Ultrasound, University of Washington, Seattle, WA 98195, USA. 4. Department of Neurological Surgery, University of Washington, Seattle, WA 98109, USA. 5. Department of Pediatrics, University of Washington, Seattle, WA 98195, USA. 6. Center for Industrial and Medical Ultrasound, University of Washington, Seattle, WA 98195, USA. 7. Department of Chemistry, Lanzhou University, Lanzhou 730000, China. 8. Department of Neurological Surgery, University of Washington, Seattle, WA 98109, USA. Electronic address: pjhorner@houstonmethodist.org. 9. Department of Bioengineering, University of Washington, Seattle, WA 98195, USA; Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA. Electronic address: spun@uw.edu.
Abstract
Neurons in the brain can be damaged or lost from neurodegenerative disease, stroke, or traumatic injury. Although neurogenesis occurs in mammalian adult brains, the levels of natural neurogenesis are insufficient to restore function in these cases. Gene therapy has been pursued as a promising strategy to induce differentiation of neural progenitor cells into functional neurons. Non-viral vectors are a preferred method of gene transfer due to potential safety and manufacturing benefits but suffer from lower delivery efficiencies compared to viral vectors. Since the neural stem and progenitor cells reside in the subventricular zone of the brain, intraventricular injection has been used as an administration route for gene transfer to these cells. However, the choroid plexus epithelium remains an obstacle to delivery. Recently, transient disruption of the blood-brain barrier by microbubble-enhanced ultrasound has been used to successfully improve drug delivery to the brain after intravenous injection. In this work, we demonstrate that microbubble-enhanced ultrasound can similarly improve gene transfer to the subventricular zone after intraventricular injection. Microbubbles of different surface charges (neutral, slightly cationic, and cationic) were prepared, characterized by acoustic flow cytometry, and evaluated for their ability to increase the permeability of immortalized choroid plexus epithelium monolayers in vitro. Based on these results, slightly cationic microbubbles were evaluated for microbubble and ultrasound-mediated enhancement of non-viral gene transfer in vivo. When coupled with our previously reported gene delivery vehicles, the slightly cationic microbubbles significantly increased ultrasound-mediated transfection of the murine brain when compared to commercially available Definity® microbubbles. Temporary disruption of the choroid plexus by microbubble-enhanced ultrasound is therefore a viable way of enhancing gene delivery to the brain and merits further research.
Neurons in the brain can be damaged or lost from n class="Disease">neurodegenerative disease, n class="Disease">stroke, or traumatic injury. Although neurogenesis occurs in mammalian adult brains, the levels of natural neurogenesis are insufficient to restore function in these cases. Gene therapy has been pursued as a promising strategy to induce differentiation of neural progenitor cells into functional neurons. Non-viral vectors are a preferred method of gene transfer due to potential safety and manufacturing benefits but suffer from lower delivery efficiencies compared to viral vectors. Since the neural stem and progenitor cells reside in the subventricular zone of the brain, intraventricular injection has been used as an administration route for gene transfer to these cells. However, the choroid plexus epithelium remains an obstacle to delivery. Recently, transient disruption of the blood-brain barrier by microbubble-enhanced ultrasound has been used to successfully improve drug delivery to the brain after intravenous injection. In this work, we demonstrate that microbubble-enhanced ultrasound can similarly improve gene transfer to the subventricular zone after intraventricular injection. Microbubbles of different surface charges (neutral, slightly cationic, and cationic) were prepared, characterized by acoustic flow cytometry, and evaluated for their ability to increase the permeability of immortalized choroid plexus epithelium monolayers in vitro. Based on these results, slightly cationic microbubbles were evaluated for microbubble and ultrasound-mediated enhancement of non-viral gene transfer in vivo. When coupled with our previously reported gene delivery vehicles, the slightly cationic microbubbles significantly increased ultrasound-mediated transfection of the murine brain when compared to commercially available Definity® microbubbles. Temporary disruption of the choroid plexus by microbubble-enhanced ultrasound is therefore a viable way of enhancing gene delivery to the brain and merits further research.
Authors: Francesca Cavalieri; James P Best; Camilo Perez; Juan Tu; Frank Caruso; Thomas J Matula; Muthupandian Ashokkumar Journal: ACS Appl Mater Interfaces Date: 2013-10-29 Impact factor: 9.229
Authors: Martin M Mortazavi; Christoph J Griessenauer; Nimer Adeeb; Aman Deep; Reza Bavarsad Shahripour; Reza Bavarsad Shahripour; Marios Loukas; Richard Isaiah Tubbs; R Shane Tubbs Journal: Childs Nerv Syst Date: 2013-11-28 Impact factor: 1.475
Authors: Feng Xie; Michael D Boska; John Lof; Mariano G Uberti; Jeane M Tsutsui; Thomas R Porter Journal: Ultrasound Med Biol Date: 2008-08-09 Impact factor: 2.998
Authors: Stephen Dicker; Michał Mleczko; Monica Siepmann; Nicole Wallace; Youhan Sunny; Christopher R Bawiec; Georg Schmitz; Peter Lewin; Steven P Wrenn Journal: Ultrasound Med Biol Date: 2013-05-15 Impact factor: 2.998
Authors: James-Kevin Y Tan; Drew L Sellers; Binhan Pham; Suzie H Pun; Philip J Horner Journal: Front Mol Neurosci Date: 2016-11-01 Impact factor: 5.639
Authors: Dominic M Tran; Feng Zhang; Kyle P Morrison; Keith R Loeb; James Harrang; Masaki Kajimoto; Francisco Chavez; Li Wu; Carol H Miao Journal: Mol Ther Methods Clin Dev Date: 2019-07-26 Impact factor: 6.698